Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS (Centers for Medicare & Medicaid Services) agrees to review carotid stenting policy

This article was originally published in Clinica

Executive Summary

The Centers for Medicare & Medicaid Services (CMS) has agreed to consider withdrawing its current non-coverage instructions for carotid artery stenting in light of the results from Cordis' recent SAPPHIRE trial. The Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy trial demonstrated that carotid stenting with embolic protection is not inferior to carotid endarterectomy and is a viable alternative for those patients who might not do well with the more invasive surgical procedure.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058836

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel